Advertisement
UK markets open in 3 hours 58 minutes
  • NIKKEI 225

    37,780.35
    +151.87 (+0.40%)
     
  • HANG SENG

    17,540.88
    +256.34 (+1.48%)
     
  • CRUDE OIL

    83.78
    +0.21 (+0.25%)
     
  • GOLD FUTURES

    2,345.10
    +2.60 (+0.11%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • Bitcoin GBP

    51,582.32
    +152.55 (+0.30%)
     
  • CMC Crypto 200

    1,390.91
    +8.34 (+0.60%)
     
  • NASDAQ Composite

    15,611.76
    -100.99 (-0.64%)
     
  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     

Why InMode Ltd.’s (NASDAQ:INMD) Return On Capital Employed Is Impressive

Today we'll look at InMode Ltd. (NASDAQ:INMD) and reflect on its potential as an investment. Specifically, we're going to calculate its Return On Capital Employed (ROCE), in the hopes of getting some insight into the business.

Firstly, we'll go over how we calculate ROCE. Next, we'll compare it to others in its industry. Finally, we'll look at how its current liabilities affect its ROCE.

Return On Capital Employed (ROCE): What is it?

ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. All else being equal, a better business will have a higher ROCE. Ultimately, it is a useful but imperfect metric. Renowned investment researcher Michael Mauboussin has suggested that a high ROCE can indicate that 'one dollar invested in the company generates value of more than one dollar'.

So, How Do We Calculate ROCE?

The formula for calculating the return on capital employed is:

ADVERTISEMENT

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

Or for InMode:

0.31 = US$51m ÷ (US$190m - US$24m) (Based on the trailing twelve months to September 2019.)

Therefore, InMode has an ROCE of 31%.

See our latest analysis for InMode

Is InMode's ROCE Good?

When making comparisons between similar businesses, investors may find ROCE useful. InMode's ROCE appears to be substantially greater than the 8.9% average in the Medical Equipment industry. We consider this a positive sign, because it suggests it uses capital more efficiently than similar companies. Regardless of the industry comparison, in absolute terms, InMode's ROCE currently appears to be excellent.

The image below shows how InMode's ROCE compares to its industry, and you can click it to see more detail on its past growth.

NasdaqGS:INMD Past Revenue and Net Income, December 23rd 2019
NasdaqGS:INMD Past Revenue and Net Income, December 23rd 2019

When considering this metric, keep in mind that it is backwards looking, and not necessarily predictive. Companies in cyclical industries can be difficult to understand using ROCE, as returns typically look high during boom times, and low during busts. ROCE is only a point-in-time measure. Future performance is what matters, and you can see analyst predictions in our free report on analyst forecasts for the company.

What Are Current Liabilities, And How Do They Affect InMode's ROCE?

Current liabilities include invoices, such as supplier payments, short-term debt, or a tax bill, that need to be paid within 12 months. The ROCE equation subtracts current liabilities from capital employed, so a company with a lot of current liabilities appears to have less capital employed, and a higher ROCE than otherwise. To counter this, investors can check if a company has high current liabilities relative to total assets.

InMode has total assets of US$190m and current liabilities of US$24m. As a result, its current liabilities are equal to approximately 12% of its total assets. This is quite a low level of current liabilities which would not greatly boost the already high ROCE.

Our Take On InMode's ROCE

This is good to see, and with such a high ROCE, InMode may be worth a closer look. There might be better investments than InMode out there, but you will have to work hard to find them . These promising businesses with rapidly growing earnings might be right up your alley.

If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.